Why Jaguar Health (JAGX) Stock Is Trading Lower

Jaguar Health Inc JAGX shares are trading lower by 40.1% to 28 cents during Tuesday’s session after the company announced a 1-for-25 reverse stock split of its common stock, set to take effect on March 24, to maintain compliance with Nasdaq listing requirements.

The stock will trade on a split-adjusted basis under the same ticker. CEO Lisa Conte stated the move aims to attract institutional investors by adjusting the share price and count.

Approved by stockholders at a Special Meeting, the split will convert every 25 shares into one without changing par value.

No fractional shares will be issued, and stockholders will receive cash for fractions. Equiniti Trust Company, LLC will manage the exchange, with brokerage account holders requiring no action.

Read Also: Stock Of The Day – Does Classic Pattern In Microsoft Mean A Move Higher?

Is JAGX A Good Stock To Buy?

An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Jaguar Health‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.

Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Jaguar Health will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.

According to data from Benzinga Pro, JAGX has a 52-week high of $21.60 and a 52-week low of $0.32.